These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33301908)

  • 1. The COVID-19 pandemic and a reflection on the conduct of clinical trials in times of war.
    Pacheco RL; Cabrera Martimbianco AL; Riera R
    J Clin Epidemiol; 2021 Apr; 132():131-132. PubMed ID: 33301908
    [No Abstract]   [Full Text] [Related]  

  • 2. The Impact of Armed Conflict on the Epidemiological Situation of COVID-19 in Libya, Syria and Yemen.
    Daw MA
    Front Public Health; 2021; 9():667364. PubMed ID: 34178925
    [No Abstract]   [Full Text] [Related]  

  • 3. The COVID-19 pandemic and war.
    Gugushvili A; Mckee M
    Scand J Public Health; 2022 Feb; 50(1):16-18. PubMed ID: 33612033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation in the COVID-19 pandemic as re-traumatization of war experiences.
    Okorn I; Jahović S; Dobranić-Posavec M; Mladenović J; Glasnović A
    Croat Med J; 2020 Aug; 61(4):371-376. PubMed ID: 32881436
    [No Abstract]   [Full Text] [Related]  

  • 5. Will patient-centric sampling become the norm for clinical trials after COVID-19?
    James CA; Barfield MD; Maass KF; Patel SR; Anderson MD
    Nat Med; 2020 Dec; 26(12):1810. PubMed ID: 33230340
    [No Abstract]   [Full Text] [Related]  

  • 6. Remote Monitoring in Clinical Trials During the COVID-19 Pandemic.
    Izmailova ES; Ellis R; Benko C
    Clin Transl Sci; 2020 Sep; 13(5):838-841. PubMed ID: 32526077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. It is unprecedented: trial management during the COVID-19 pandemic and beyond.
    Mitchell EJ; Ahmed K; Breeman S; Cotton S; Constable L; Ferry G; Goodman K; Hickey H; Meakin G; Mironov K; Quann N; Wakefield N; McDonald A
    Trials; 2020 Sep; 21(1):784. PubMed ID: 32917258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Audio Interview: Caring for Patients with Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Apr; 382(16):e50. PubMed ID: 32294372
    [No Abstract]   [Full Text] [Related]  

  • 9. A Call for Pediatric COVID-19 Clinical Trials.
    Campbell JI; Ocwieja KE; Nakamura MM
    Pediatrics; 2020 Aug; 146(2):. PubMed ID: 32398330
    [No Abstract]   [Full Text] [Related]  

  • 10. Does the COVID-19 outbreak identify a broader need for an urgent transformation of cancer clinical trials research?
    Borno HT; Small EJ
    Contemp Clin Trials; 2020 May; 92():105997. PubMed ID: 32272172
    [No Abstract]   [Full Text] [Related]  

  • 11. An expression of concern on research during the Covid-19 pandemic.
    Calcaterra G; Bassareo PP; Nodari S; Barilla' F; Di Franco A; Romeo F
    J Cardiovasc Med (Hagerstown); 2020 Oct; 21(10):838-839. PubMed ID: 32740445
    [No Abstract]   [Full Text] [Related]  

  • 12. [Not Available].
    Fumeaux T
    Rev Med Suisse; 2020 Jun; 16(697):1220. PubMed ID: 32520466
    [No Abstract]   [Full Text] [Related]  

  • 13. The Landscape of Cardiovascular Clinical Trials in the United States Initiated Before and During COVID-19.
    Selvaraj S; Greene SJ; Khatana SAM; Nathan AS; Solomon SD; Bhatt DL
    J Am Heart Assoc; 2020 Sep; 9(18):e018274. PubMed ID: 32713281
    [No Abstract]   [Full Text] [Related]  

  • 14. Challenges in Drug Development Posed by the COVID-19 Pandemic: An Opportunity for Clinical Pharmacology.
    Venkatakrishnan K; Yalkinoglu O; Dong JQ; Benincosa LJ
    Clin Pharmacol Ther; 2020 Oct; 108(4):699-702. PubMed ID: 32356569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of the global COVID-19 pandemic on the conduct of clinical trials: Return to normalcy by considering the practical impact of a structured ethical analysis.
    Vissers MFJM; Cohen AF; Van Gerven JMA; Groeneveld GJ
    Br J Clin Pharmacol; 2021 Mar; 87(3):837-844. PubMed ID: 32668047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Trial End Points in Severe COVID-19.
    Desai A; Kulkarni A; Rajkumar SV; Gyawali B
    Mayo Clin Proc; 2020 Aug; 95(8):1578-1580. PubMed ID: 32753131
    [No Abstract]   [Full Text] [Related]  

  • 17. Conducting clinical trials during the COVID-19 pandemic.
    Collier EK; Hsiao JL; Shi VY
    J Dermatolog Treat; 2020 Jun; 31(4):330-332. PubMed ID: 32343162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea.
    Jeon J; Kim H; Yu KS
    J Korean Med Sci; 2020 Sep; 35(36):e329. PubMed ID: 32924344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart Failure Collaboratory Statement on Clinical Trials in the Landscape of COVID-19.
    Abraham WT; Fiuzat M; Psotka MA; O'Connor CM
    JACC Heart Fail; 2020 May; 8(5):423-425. PubMed ID: 32354417
    [No Abstract]   [Full Text] [Related]  

  • 20. Must there be a "war" against coronavirus?
    Rohela P; Bhan A; Ravindranath D; Bose DL; Pathare S
    Indian J Med Ethics; 2020; V(3):222-226. PubMed ID: 33295288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.